FDA Approves Landmark Pancreatic Cancer Drug That's Shown to Improve Survival The US Food and Drug Administration has approved a new pancreatic cancer treatment that targets the PD 1 protein, a key fuel source for tumor growth.
This breakthrough offers hope to patients and families affected by this aggressive disease.
The Elusive Pancreatic Cancer Puzzle Pancreatic cancer is notoriously difficult to treat, with a staggering 92% of patients dying within five years of diagnosis.